Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Short Description: Ondansetron oral
Coverage Code: Special coverage instructions apply
Action Code: No maintenance for this code
Date Added: January 1, 2012
Effective Date: January 1, 2012
Termination Date: